Table 3. Comparison of patients with and without significant hepatic steatosis.
| Variable | No significant-hepatic steatosis (n = 170, 55.9%) | Hepatic steatosis (n = 134, 44.1%) | P value |
|---|---|---|---|
| Age, years | 55.5 ± 11.5 | 57.7 ± 9.7 | NS |
| Male gender (%) | 49 (36.6) | 90 (52.9%) | 0.005 |
| Medical history | |||
| Diabetes mellitus | 7 (4.1) | 15 (11.2) | NS |
| Hypertension | 26 (15.3) | 18 (13.4) | NS |
| Body mass index, kg/m2 | 23.0 ± 2.6 | 25.5 ± 3.1 | <0.001 |
| Waist/hip ratio | 0.86 ± 0.04 | 0.90 ± 0.04 | 0.001 |
| Visceral fat area, cm2 | 95.6 ± 41.9 | 131.5 ± 53.7 | <0.001 |
| Subcutaneous fat area, cm2 | 162.7 ± 56.5 | 191.3 ± 60.8 | <0.001 |
| Laboratory profiles | |||
| Fasting glucose, mg/mL | 95.7 ± 23.7 | 104.8 ± 23.8 | 0.001 |
| Cholesterol, mg/mL | 182.3 ± 39.6 | 187.4 ± 35.3 | NS |
| Triglycerides, mg/mL | 100.1 ± 52.6 | 133.8 ± 71.4 | <0.001 |
| AST, IU/L | 21.9 ± 7.2 | 24.3 ± 9.8 | NS |
| ALT, IU/L | 20.5 ± 10.4 | 26.5 ± 16.1 | <0.001 |
| γ-GTP, IU/L | 29.8 ± 29.5 | 37.5 ± 32.3 | 0.031 |
| ESR, mm/h | 17.1 ± 15.1 | 17.6 ± 16.2 | NS |
| Liver stiffness value, kPa | 4.5 (2.1–21.8) | 4.6 (2.8–14.3) | NS |
Variables are expressed as mean ± standard deviation, median (range), or number (%).
NS, not significant; AST, aspartate aminotransferase; ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; ESR, erythrocyte sedimentation rate